ELIC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Elicera Therapeutics AB

Watchlist Manager

Watchlist

Price: 2.33 SEK -2.51% Market Closed

Market Cap: kr169.6m

E	Elicera Therapeutics AB STO:ELIC	SE
B	BNP Paribas SA MIL:BNP	FR
	Roper Technologies Inc SIX:ROP	US
K	Kohls Corp F:KHP	US
W	Walmart Inc LSE:0R1W	US
	RS Group PLC LSE:RS1	UK
	Ondas Holdings Inc NASDAQ:ONDS	US
	SoFi Technologies Inc MIL:1SOFI	US

Profitability Summary

Elicera Therapeutics AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-141%

Negative 3Y Average Operating Margin

-222%

Operating Margin is Increasing

-434% > -141%

Negative Net Margin

-136%

Negative 3Y Average Net Margin

-213%

Net Margin is Increasing

-431% > -136%

Negative Free Cash Flow Margin

-261%

Negative 3Y Average Free Cash Flow Margin

-226%

Free Cash Flow Margin is Increasing

-312% > -261%

Negative ROE

-57%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

2.515%

ROIC is Increasing

1.230% > 3.274%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.